Figure 1.

Study flow. Study flow of patients referred for colonoscopy and esophagogastroduodenoscopy (EGD). A total of 37 patients were excluded from the final analysis, in 29 patients because follow-up endoscopy was not performed as required by the protocol (no clinically significant lesion on endoscopy but fecal calprotectin > 50 μg/g)

Manz et al. BMC Gastroenterology 2012 12:5   doi:10.1186/1471-230X-12-5
Download authors' original image